In search of an optimum dose escalation for narrowband UVB phototherapy: Is it time to quit 20% increments?


Boztepe G., Akinci H., Sahin S., Karaduman A., Evans S. E., Erkin G., ...Daha Fazla

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, cilt.55, sa.2, ss.269-271, 2006 (SCI-Expanded) identifier identifier identifier

Özet

Objectives: Our aim was to compare 20% with 10% to 5% incremental regimens in narrowband UVB phototherapy.